A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP)

被引:94
作者
Davis, CM [1 ]
Sumrall, KH [1 ]
Vincent, JB [1 ]
机构
[1] UNIV ALABAMA, DEPT CHEM, TUSCALOOSA, AL 35487 USA
关键词
D O I
10.1021/bi960328y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chromium is essential for proper carbohydrate and lipid metabolism in mammals, although the mechanism of this action has previously proved elusive. Low-molecular-weight chromium-binding protein (LMWCr), a biologically active form of chromium in mammals, potentiates the effect of insulin on the conversion of glucose into lipid and into carbon dioxide in isolated adipocytes. Kinetics studies indicate that LMWCr isolated from bovine liver activates phosphotyrosine phosphatase (PTP) activity in adipocyte membranes while having no intrinsic phosphatase activity. This activation is directly proportional to the amount of added LMWCr. The pattern of inhibition of this activity in the presence of a number of known phosphatase inhibitors suggests the involvement of a membrane phosphotyrosine phosphatase similar to PTP1A' or PTP1B. We propose that chromium plays a biological role in the activation of a membrane phosphotyrosine phosphatase.
引用
收藏
页码:12963 / 12969
页数:7
相关论文
共 70 条
  • [1] AISEN P, 1969, J BIOL CHEM, V244, P4628
  • [2] EFFECT OF EXERCISE (RUNNING) ON SERUM GLUCOSE, INSULIN, GLUCAGON, AND CHROMIUM EXCRETION
    ANDERSON, RA
    POLANSKY, MM
    BRYDEN, NA
    ROGINSKI, EE
    PATTERSON, KY
    REAMER, DC
    [J]. DIABETES, 1982, 31 (03) : 212 - 216
  • [3] SUPPLEMENTAL-CHROMIUM EFFECTS ON GLUCOSE, INSULIN, GLUCAGON, AND URINARY CHROMIUM LOSSES IN SUBJECTS CONSUMING CONTROLLED LOW-CHROMIUM DIETS
    ANDERSON, RA
    POLANSKY, MM
    BRYDEN, NA
    CANARY, JJ
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 54 (05) : 909 - 916
  • [4] CHROMIUM INTAKE, ABSORPTION AND EXCRETION OF SUBJECTS CONSUMING SELF-SELECTED DIETS
    ANDERSON, RA
    KOZLOVSKY, AS
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1985, 41 (06) : 1177 - 1183
  • [5] EFFECTS OF SUPPLEMENTAL CHROMIUM ON PATIENTS WITH SYMPTOMS OF REACTIVE HYPOGLYCEMIA
    ANDERSON, RA
    POLANSKY, MM
    BRYDEN, NA
    BHATHENA, SJ
    CANARY, JJ
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (04): : 351 - 355
  • [6] ANDERSON RA, 1986, CLIN PHYSIOL BIOCH, V4, P31
  • [7] IMPROVED ASSAY FOR BIOLOGICALLY-ACTIVE CHROMIUM
    ANDERSON, RA
    BRANTNER, JH
    POLANSKY, MM
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1978, 26 (05) : 1219 - 1221
  • [8] CHROMIUM SUPPLEMENTATION OF HUMAN-SUBJECTS - EFFECTS ON GLUCOSE, INSULIN, AND LIPID VARIABLES
    ANDERSON, RA
    POLANSKY, MM
    BRYDEN, NA
    ROGINSKI, EE
    MERTZ, W
    GLINSMANN, W
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (09): : 894 - 899
  • [9] ANDERSON RA, 1994, RISK ASSESSMENT OF ESSENTIAL ELEMENTS, P187
  • [10] URINARY CHROMIUM EXCRETION AND INSULINOGENIC PROPERTIES OF CARBOHYDRATES
    ANDERSON, RA
    BRYDEN, NA
    POLANSKY, MM
    REISER, S
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (05) : 864 - 868